Isolation and characterization of two Korean mistletoe lectins

Area of Science:

• Biochemistry
• Immunology
• Pharmacology

Background:

• Korean mistletoe lectin (KML-C) is a known bioactive compound.
• Lectins are proteins with specific carbohydrate-binding properties.
• Understanding isolectin variations is crucial for therapeutic development.

Purpose of the Study:

• To isolate and characterize two distinct isolectins from KML-C: KML-IIU and KML-IIL.
• To compare the biophysical properties and bioactivities of KML-IIU and KML-IIL.
• To evaluate the potential of these isolectins as anti-cancer agents.

Main Methods:

• Immunoaffinity chromatography was used for isolectin isolation.
• Molecular weights were determined.
• Carbohydrate-binding specificities were assessed.
• Cytotoxicity assays were performed on various cancer cell lines.
• Tumor necrosis factor-alpha (TNF-alpha) secretion was measured in macrophages.

Main Results:

• Two isolectins, KML-IIU (64 kDa) and KML-IIL (60 kDa), were successfully isolated.
• Both isolectins bind to Gal and GalNAc but differ in glycosylation and amino acid composition.
• KML-IIL demonstrated significantly higher cytotoxicity (17-145 times) against cancer cells compared to KML-IIU.
• KML-IIL induced 4.5 times more TNF-alpha secretion from macrophages than KML-IIU.

Conclusions:

• Isolectins from Korean mistletoe exhibit distinct bioactivities.
• KML-IIL possesses superior cytotoxic and immune-stimulating properties compared to KML-IIU.
• KML-IIL shows promise as a potential anti-cancer therapeutic agent.